Clinical Trials

13 enrolled

Neoplasms, Plasma Cell

NCT05182073 2025-12-12

FT576 in Subjects With Multiple Myeloma

31 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT05065866 2025-12-04

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

LymphoidOther hematologic neoplasmPlasma cell

14 enrolled

Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

NCT02244125 2025-11-24

PCD

100 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01526096 2025-11-05

Stem Cell Transplantation for Patients With Multiple Myeloma

30 enrolled

Neoplasms, Plasma Cell

NCT07206810 2025-10-03

A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients

419 enrolled

Phase EARLY_PHASE1 Completed

Neoplasms, Plasma Cell

NCT04862676 2025-09-10

Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT

29 enrolled

Neoplasms, Plasma Cell

NCT03951220 2025-08-19

LOOMIS

67 enrolled 24 charts

Classical hematologyPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

108 enrolled

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT04194840 2025-08-05

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

20 enrolled

Lymphoma, Neoplasms, Plasma Cell

NCT06504524 2025-06-27

A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

633 enrolled 15 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01350245 2025-05-16

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

28 enrolled 10 charts

Anemia, Aplastic, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT06892119 2025-03-27

Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation

6 enrolled

Lymphoma, Neoplasms, Plasma Cell

NCT00120263 2025-03-25

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

92 enrolled

GenitourinaryPlasma cell

Multiple Myeloma, Neoplasms, Plasma Cell, Acute Kidney Injury

NCT06610045 2025-03-13

The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study

400 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT04080531 2025-02-28

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Phase 4 Completed

165 enrolled 9 charts

Neoplasms, Plasma Cell

NCT04999085 2025-02-28

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

16 enrolled 8 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03398200 2025-02-07

Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma

99 enrolled 12 charts

Neoplasms, Plasma Cell

NCT03773107 2025-01-13

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Phase 1/2 Completed

12 enrolled 19 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT05061095 2024-12-27

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey

LymphoidMyeloidOther hematologic neoplasmPlasma cell

51 enrolled 8 charts

Leukemia, Lymphoma, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT03006315 2024-11-19

Mobile Health Device Study for Myeloma Patients

40 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00482261 2024-11-08

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

150 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT05260203 2024-11-06

MargheRITA

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

124 enrolled

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT05932290 2024-10-29

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

514 enrolled 16 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell

NCT05101759 2024-09-25

LYMPHOLD

100 enrolled

Lymphoma, Neoplasms, Plasma Cell

NCT01183949 2024-08-02

Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma

Phase 1/2 Completed

18 enrolled

Blood Protein Disorders, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT04394650 2024-07-26

A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

78 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01283997 2024-06-13

Prevention of Treatment Induced Neuropathy in Multiple Myeloma

79 enrolled 10 charts

cyclopia sequence, Multiple Myeloma, Neoplasms, Plasma Cell

NCT03184194 2024-05-22

Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide

62 enrolled

Neoplasms, Plasma Cell

NCT05565391 2024-05-21

A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

508 enrolled 16 charts

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01063907 2024-04-25

A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma

Phase 1/2 Completed

95 enrolled 13 charts

Bronchiolitis Obliterans Syndrome, Blood Protein Disorders, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias, Leukemia, B-Cell, Neoplasms, Plasma Cell

NCT00019097 2024-03-04

Vaccine Therapy in Treating Patients With Multiple Myeloma

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms, Genetic Diseases, Inborn, Neoplasms, Plasma Cell

NCT02140736 2024-02-28

ORHEO

2,333 enrolled

Lymphoma, Neoplasms, Plasma Cell

NCT06212596 2024-01-19

MUKtwelve

66 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01454297 2024-01-03

CoMMpass

1,154 enrolled